# GLP-1s and menopause · PepVault guides

Source: https://pepvault.app/guides/glp-1s-and-menopause

Last updated: 2026-11-20

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Guides](https://pepvault.app/guides) [GLP-1s](https://pepvault.app/guides#glp1)

# GLP-1s and menopause: what the trials say about women in midlife

Reviewed November 2026 13 sources [Published by PepVault](https://pepvault.app/guides/how-we-research)

GLP-1s in menopause: tirzepatide weight loss by menopause stage, semaglutide with hormone therapy, the pill, bone and fractures, and the hot-flash trials.

- **Last reviewed:** Nov 20, 2026
- **Sources:** 13
- **Questions:** 7
- **Compounds:** 2

## The short answer

In the trials, menopause did not blunt GLP-1 weight loss. In a post hoc analysis of SURMOUNT-1, women on tirzepatide 15 mg lost 23 to 26% of their body weight at 72 weeks whether they were before, during or after menopause, against 2 to 3% on placebo. Two Mayo Clinic chart reviews, one per drug, found more loss in women also taking menopause hormone therapy.

Every number checked at its primary source · Nov 20, 2026 · [13 sources](https://pepvault.app/guides/glp-1s-and-menopause#sources) · [How we research](https://pepvault.app/guides/how-we-research)

**Evidence:** Post hoc analyses of randomised phase 3 trials (SURMOUNT-1, -3 and -4) for tirzepatide, observational clinic studies for semaglutide and tirzepatide, FDA label data, a meta-analysis of placebo-controlled trials of mostly older GLP-1s, and two 2026 reviews; no randomised trial of a GLP-1 for menopause symptoms has reported. Tirzepatide (Zepbound) and semaglutide (Wegovy) are FDA-approved for weight management.

## Does tirzepatide work as well after menopause?

Yes, nearly as well. Researchers, most of them Eli Lilly employees, went back through three SURMOUNT trials and sorted 2,542 women without diabetes into premenopause, perimenopause (the transition years, when periods become irregular) and postmenopause[1](https://pepvault.app/guides/glp-1s-and-menopause#source-1). The trials had not recorded menopause, so this is a **post hoc analysis**: one done after the trial, on groups it was not designed to compare. Most women were placed by age alone: under 45 counted as premenopausal, 45 to 54 as perimenopausal unless something showed otherwise, and 55 or older as postmenopausal[1](https://pepvault.app/guides/glp-1s-and-menopause#source-1).

In SURMOUNT-1, the largest of the three, the groups averaged 34, 45 and 58 years old. At week 72 on tirzepatide 15 mg the result barely moved across them. These are the abstract's figures; the paper's results text gives the tirzepatide range as 24 to 26%[1](https://pepvault.app/guides/glp-1s-and-menopause#source-1):

| SURMOUNT-1, week 72 | Premenopause | Perimenopause | Postmenopause |
| --- | --- | --- | --- |
| Women in the analysis (all arms) | 697 | 429 | 581 |
| Body weight, tirzepatide 15 mg vs placebo | −26% vs −2% | −23% vs −3% | −23% vs −3% |
| Waist, tirzepatide 15 mg vs placebo | −22 cm vs −4 cm | −20 cm vs −5 cm | −20 cm vs −4 cm |
| Reached a low-risk waist-to-height ratio (BMI under 35) | 52% vs 6% | 30% vs 0% | 30% vs 0% |

The waist matters here. Around menopause fat tends to move to the middle, and the authors chose the waist-to-height ratio because it tracks that central fat better than BMI does; 0.49 or below counts as low risk[1](https://pepvault.app/guides/glp-1s-and-menopause#source-1). Across all three groups, 97 to 98% of women on tirzepatide lost at least 5% of their weight, against 29 to 33% on placebo, and SURMOUNT-3 and SURMOUNT-4 showed the same pattern[1](https://pepvault.app/guides/glp-1s-and-menopause#source-1). Women past menopause started with more high blood pressure, high cholesterol and prediabetes: half of them had prediabetes, against 29% before menopause[1](https://pepvault.app/guides/glp-1s-and-menopause#source-1).

<!--promo-->

PepVault's weight log charts the scale week by week, and a body check-in records your waist, the measure this analysis followed. [Track your weight in PepVault](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-glp-1s-and-menopause-inline&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

PepVault's weight log charts the scale week by week, and a body check-in records your waist, the measure this analysis followed.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What about semaglutide in women after menopause?

Semaglutide has no published STEP trial analysis by menopause stage that we could find. Wegovy's label states only that weight fell irrespective of age, sex, race, ethnicity and starting BMI[5](https://pepvault.app/guides/glp-1s-and-menopause#source-5). The menopause-specific evidence is observational: studies of people treated in ordinary care, with no placebo group.

The best known is from the Mayo Clinic. It looked back at 106 postmenopausal women treated with semaglutide for at least three months, 16 of whom were also on menopause hormone therapy (estradiol as a patch or a pill, with a progestogen if they still had a uterus)[2](https://pepvault.app/guides/glp-1s-and-menopause#source-2). The women on hormone therapy lost more at every checkpoint[2](https://pepvault.app/guides/glp-1s-and-menopause#source-2):

| Months on semaglutide | With hormone therapy (16 women) | Without (90 women) |
| --- | --- | --- |
| 3 | 7% | 5% |
| 6 | 13% | 9% |
| 9 | 15% | 10% |
| 12 | 16% | 12% |

The gap held after the authors adjusted for dose and other factors, and it was the same whether the estradiol came as a patch or a pill[2](https://pepvault.app/guides/glp-1s-and-menopause#source-2). A Spanish clinic study found that four months of semaglutide 1 mg took off about 5 to 6% of body weight in postmenopausal and premenopausal women alike, with similar fat loss[3](https://pepvault.app/guides/glp-1s-and-menopause#source-3).

## Does hormone therapy make a GLP-1 work better?

Possibly, and the signal now comes from both drugs. A second Mayo Clinic chart review followed 120 postmenopausal women on tirzepatide for a year or more, 40 of them on hormone therapy; by Mayo's account of the paper, those on hormone therapy lost about 35% more weight[13](https://pepvault.app/guides/glp-1s-and-menopause#source-13). Both studies are observational, and women who take hormone therapy can differ from those who don't in ways a chart review cannot see; both author groups call for prospective studies[2](https://pepvault.app/guides/glp-1s-and-menopause#source-2) [13](https://pepvault.app/guides/glp-1s-and-menopause#source-13). The Spanish Menopause Society's 2026 position statement reads the link as hypothesis-generating and says it should not be a reason to start hormone therapy only to lose more weight[9](https://pepvault.app/guides/glp-1s-and-menopause#source-9). Hormone therapy is chosen for menopause symptoms and bone, on its own merits.

A direct test is under way. A randomised trial at University Hospital Bern in Switzerland is giving 96 early postmenopausal women with prediabetes or type 2 diabetes an estradiol patch (with progesterone if they have a uterus), semaglutide up to 1 mg, or both, for 12 weeks. Long-term blood sugar (HbA1c) is the main measure, with weight, body fat and hot flashes among the others. Its estimated primary completion is December 2026[12](https://pepvault.app/guides/glp-1s-and-menopause#source-12).

## With this guide

### Semaglutide

- [Semaglutide: the full reference](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

### Tirzepatide

- [Tirzepatide: the full reference](https://pepvault.app/peptides/tirzepatide)
- [Tirzepatide dose guide](https://pepvault.app/lab/dosage/tirzepatide)

### Mixing charts

- [Semaglutide 2 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-2mg)
- [Semaglutide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-5mg)
- [Semaglutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-10mg)
- [Tirzepatide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-5mg)
- [Tirzepatide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-10mg)
- [Tirzepatide 15 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-15mg)
- [Tirzepatide 30 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-30mg)
- [Tirzepatide 60 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-60mg)

### Studies

- [Semaglutide: 11.85% more weight loss than placebo without diabetes](https://pepvault.app/research/semaglutide-tan-2022)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [CagriSema: HbA1c down 2.33% at 40 weeks in REIMAGINE 3](https://pepvault.app/research/cagrisema-reimagine-3-2026)
- [All 31 studies](https://pepvault.app/research#semaglutide)
- [Tirzepatide plus apitegromab: 1.9 kg less lean mass loss in EMBRAZE](https://pepvault.app/research/tirzepatide-embraze-2026)
- [Tirzepatide SURMOUNT-MAINTAIN: 21.9% weight loss at 112 weeks](https://pepvault.app/research/tirzepatide-surmount-maintain-2026)
- [Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c](https://pepvault.app/research/dulaglutide-surpass-switch-2025)
- [All 19 studies](https://pepvault.app/research#tirzepatide)

### Compared with

- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)
- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)
- [Semaglutide vs Dulaglutide](https://pepvault.app/peptides/compare/semaglutide-vs-dulaglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### The GLP-1 path

- [Retatrutide week by week](https://pepvault.app/guides/retatrutide-week-by-week)
- [Retatrutide dosage: the trial step-ups](https://pepvault.app/guides/retatrutide-dosage-in-trials)
- [Tirzepatide week by week](https://pepvault.app/guides/tirzepatide-week-by-week)
- [Semaglutide week by week](https://pepvault.app/guides/semaglutide-week-by-week)
- [Tirzepatide dosage: every step from 2.5 to 15 mg (Mounjaro and Zepbound)](https://pepvault.app/guides/tirzepatide-dosage)
- [Wegovy and Ozempic dosage: both labels' steps in one table, and why the two differ](https://pepvault.app/guides/wegovy-and-ozempic-dosage)
- [How to use the Zepbound KwikPen](https://pepvault.app/guides/how-to-use-the-zepbound-kwikpen)
- [How to use the Ozempic and Wegovy pens: needles, the dose counter and clicks](https://pepvault.app/guides/how-to-use-ozempic-and-wegovy-pens)
- [What time of day to take your GLP-1 shot or pill, and can you change the day?](https://pepvault.app/guides/when-to-take-your-glp-1)
- [Switching GLP-1s: Ozempic to Zepbound, shot to pill, and what the trials tested](https://pepvault.app/guides/switching-between-glp-1s)
- [Ozempic vs Wegovy vs Mounjaro vs Zepbound: the four labels in one table](https://pepvault.app/guides/ozempic-wegovy-mounjaro-zepbound)
- [Is Ozempic insulin? GLP-1, GIP and insulin explained](https://pepvault.app/guides/is-ozempic-insulin)
- [The Wegovy pill: what it is, how its label differs from the shot, and the trial numbers](https://pepvault.app/guides/the-wegovy-pill)
- [Ozempic and Wegovy side effects: what the trials counted and when they showed up](https://pepvault.app/guides/ozempic-and-wegovy-side-effects)
- [Semaglutide vs tirzepatide side effects: what the head-to-head trials found](https://pepvault.app/guides/sema-vs-tirzepatide-side-effects)
- [Microdosing a GLP-1: what it means and what has been tested](https://pepvault.app/guides/microdosing-a-glp-1)
- [GLP-1s and sleep apnea: Zepbound's OSA approval](https://pepvault.app/guides/glp-1-and-sleep-apnea)
- [Retatrutide first dose: the first four weeks in the trials](https://pepvault.app/guides/retatrutide-first-dose)
- [Retatrutide side effects: what the trials counted](https://pepvault.app/guides/retatrutide-side-effects)
- [Retatrutide not working? Stalls, slow responders and the plateau](https://pepvault.app/guides/retatrutide-not-working)
- [Switching from tirzepatide to retatrutide: what is known](https://pepvault.app/guides/tirzepatide-to-retatrutide)
- [Is retatrutide safe? What the trials reported](https://pepvault.app/guides/is-retatrutide-safe)
- [When will retatrutide be approved?](https://pepvault.app/guides/when-will-retatrutide-be-approved)
- [TRIUMPH-5 results: retatrutide vs tirzepatide head to head](https://pepvault.app/guides/triumph-5-results)
- [CagriSema FDA approval: when it's due, the dose filed, and what the trials showed](https://pepvault.app/guides/cagrisema-fda-decision)
- [MariTide phase 3 results (MARITIME-1): what to expect](https://pepvault.app/guides/maritime-1-results)
- [Aleniglipron: the GLP-1 pill, and the trial switching people from shots to it](https://pepvault.app/guides/aleniglipron-switch-trial)
- [Mounjaro and Zepbound side effects by dose: the rates at each step](https://pepvault.app/guides/mounjaro-zepbound-side-effects)
- [Hair loss on a GLP-1: how common it is per drug, and why](https://pepvault.app/guides/hair-loss-on-a-glp-1)
- ["Ozempic face": what it is, and where the weight comes from](https://pepvault.app/guides/ozempic-face)
- [Foundayo (orforglipron) vs the shots: the trial numbers side by side](https://pepvault.app/guides/foundayo-vs-the-shots)
- [Is compounded semaglutide or tirzepatide the same as Ozempic or Zepbound?](https://pepvault.app/guides/compounded-glp-1-vs-brand)
- [Why compounded semaglutide and tirzepatide come with B12, glycine or B6, and what it changes](https://pepvault.app/guides/compounded-glp-1-with-b12)
- [Is there a generic Ozempic? Generic semaglutide and Sevmia](https://pepvault.app/guides/generic-semaglutide)
- [How much does a GLP-1 cost in 2026? Zepbound, Wegovy and Medicare prices](https://pepvault.app/guides/how-much-does-a-glp-1-cost)
- [What to eat on a GLP-1: what the trials and the guidelines say](https://pepvault.app/guides/what-to-eat-on-a-glp-1)
- [How much protein per day? The numbers by weight and goal](https://pepvault.app/guides/how-much-protein-per-day)
- [Muscle on a GLP-1: how much of the weight lost is lean mass?](https://pepvault.app/guides/muscle-on-a-glp-1)
- [Intermittent fasting on a GLP-1: what the trials and labels say](https://pepvault.app/guides/intermittent-fasting-on-a-glp-1)
- [Coffee on a GLP-1: can you drink it, and why it can taste different](https://pepvault.app/guides/coffee-on-a-glp-1)
- [Food noise on a GLP-1: what it is and what happens after stopping](https://pepvault.app/guides/food-noise-on-a-glp-1)
- [Stopping a GLP-1: what happens to your weight](https://pepvault.app/guides/stopping-a-glp-1)
- [How to keep the weight off after a GLP-1: what each trial tested](https://pepvault.app/guides/keeping-weight-off-after-a-glp-1)
- [Berberine vs metformin vs a GLP-1: what each does to weight and glucose](https://pepvault.app/guides/berberine-vs-metformin-vs-glp-1)
- [Natural GLP-1 alternatives: what the evidence shows for berberine, fiber and supplements](https://pepvault.app/guides/natural-glp-1-alternatives)
- [What is 5-Amino-1MQ? What's been measured](https://pepvault.app/guides/5-amino-1mq-explained)
- [Retatrutide from a lab vial: what independent testing found](https://pepvault.app/guides/retatrutide-lab-vial-tests)
- [Switching from Saxenda to Wegovy: how the change works](https://pepvault.app/guides/saxenda-to-wegovy)
- [Do you stop Ozempic, Wegovy, Mounjaro or Zepbound before surgery?](https://pepvault.app/guides/glp-1-before-surgery)
- [Diarrhea on a GLP-1: how common, and how long it lasts](https://pepvault.app/guides/diarrhea-on-a-glp-1)
- [Dizziness on a GLP-1: dehydration, blood pressure or blood sugar?](https://pepvault.app/guides/dizziness-on-a-glp-1)
- [Heartburn and acid reflux on a GLP-1: the rates, the timing and what helps](https://pepvault.app/guides/heartburn-on-a-glp-1)
- [Does Ozempic or Mounjaro make you tired? Fatigue in the trials](https://pepvault.app/guides/glp-1-fatigue)
- [Can a GLP-1 cause low blood sugar if you do not have diabetes?](https://pepvault.app/guides/glp-1-low-blood-sugar)
- [Is there a medicine for GLP-1 nausea? Tradipitant, so far](https://pepvault.app/guides/tradipitant-for-glp-1-nausea)
- [GLP-1s and mood: depression, anxiety and what the FDA review found](https://pepvault.app/guides/glp-1s-and-mood)
- [Can Ozempic cause vision loss? GLP-1s and NAION, by the numbers](https://pepvault.app/guides/glp-1-and-naion)
- [Are GLP-1s safe long term? What the longest trials show](https://pepvault.app/guides/are-glp-1s-safe-long-term)
- [GLP-1s and the kidneys: what FLOW showed, and the dehydration risk](https://pepvault.app/guides/glp-1s-and-the-kidneys)
- [Can you drink alcohol on Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/alcohol-on-a-glp-1)
- [Do GLP-1s reduce alcohol cravings? What the trials found](https://pepvault.app/guides/glp-1-and-alcohol-cravings)
- [GLP-1s and fatty liver: what the trials measured](https://pepvault.app/guides/glp-1-and-fatty-liver)
- [GLP-1s after a gastric sleeve or bypass: regain, dosing and sleeve vs GLP-1](https://pepvault.app/guides/glp-1-after-bariatric-surgery)
- [Can you drink alcohol on retatrutide?](https://pepvault.app/guides/retatrutide-and-alcohol)
- [Ozempic, Wegovy, Mounjaro or Zepbound not working? Slow responders and plateaus in the trials](https://pepvault.app/guides/glp-1-not-working)
- [Intermittent fasting for weight and fat loss: what the trials measured](https://pepvault.app/guides/intermittent-fasting-weight-loss)
- [Can you take metformin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/metformin-with-a-glp-1)
- [GLP-1s and pregnancy: Ozempic, Wegovy, Mounjaro and Zepbound before and during](https://pepvault.app/guides/glp-1s-and-pregnancy)
- [Can you take Ozempic, Mounjaro or another GLP-1 while breastfeeding?](https://pepvault.app/guides/glp-1-while-breastfeeding)
- [Eloralintide, petrelintide and amycretin: the amylin drugs in trials](https://pepvault.app/guides/amylin-drugs-in-trials)
- [Olatorepatide (HS-20094): Regeneron's obesity drug, what is known so far](https://pepvault.app/guides/olatorepatide-explained)
- [Cagrilintide and CagriSema: what amylin adds to semaglutide](https://pepvault.app/guides/cagrilintide-and-cagrisema)
- [Berobenatide (PF-08653944, MET-097i): Pfizer's monthly GLP-1 shot, what is known so far](https://pepvault.app/guides/berobenatide-explained)
- [The GLP-1 pipeline: every drug in phase 2 and 3, and when its trials finish](https://pepvault.app/guides/glp-1-pipeline)
- [Is there a monthly GLP-1 shot? MariTide and berobenatide](https://pepvault.app/guides/monthly-glp-1-shots)
- [Cagrilintide alone: RENEW 1 phase 3 results and what to expect](https://pepvault.app/guides/renew-1-cagrilintide-results)
- [Wegovy HD: is 7.2 mg worth it, and what changes from 2.4 mg](https://pepvault.app/guides/wegovy-hd-7-2-mg)
- [Zenagamtide (amycretin): Novo's GLP-1 and amylin shot and pill, what the trials show](https://pepvault.app/guides/zenagamtide-amycretin)
- [Wegovy and Ozempic price, Medicare and WADA: what changes on January 1, 2027](https://pepvault.app/guides/glp-1-changes-january-2027)
- [Can you take sermorelin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/sermorelin-with-a-glp-1)
- [Retatrutide in women: what the studies included](https://pepvault.app/guides/retatrutide-in-women)
- [Peptides for women: what the trials in women show, and after 40](https://pepvault.app/guides/peptides-for-women)
- [Low-dose naltrexone (LDN) for weight loss: what the trials measured](https://pepvault.app/guides/ldn-for-weight-loss)
- [GLP-1s and PCOS: what the trials show, and how they compare with metformin](https://pepvault.app/guides/glp-1-and-pcos)
- [GLP-1s and sleep: insomnia, vivid dreams and the sleep apnea approval](https://pepvault.app/guides/glp-1s-and-sleep)

### Terms on this page

- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Meta-analysis](https://pepvault.app/glossary/meta-analysis)
- [Post hoc analysis](https://pepvault.app/glossary/post-hoc-analysis)
- [HbA1c (A1C)](https://pepvault.app/glossary/hba1c)
- [Body mass index (BMI)](https://pepvault.app/glossary/bmi)
- [Lean mass](https://pepvault.app/glossary/lean-mass)

## Do GLP-1s help hot flashes?

Nobody knows yet: no randomised trial has reported on it. Hot flashes and night sweats, called vasomotor symptoms, were not measured in the big weight trials. The first placebo-controlled test is a Mayo Clinic pilot that started in April 2026: 40 postmenopausal women with obesity, tirzepatide or placebo for 24 weeks, with how often and how hard the hot flashes come as the main measures. Its estimated primary completion is September 2027[11](https://pepvault.app/guides/glp-1s-and-menopause#source-11). The Bern trial above also counts hot flashes, as a secondary measure[12](https://pepvault.app/guides/glp-1s-and-menopause#source-12).

The reason to hope is indirect: in studies of midlife women, more body fat goes with more hot flashes, a link the SURMOUNT authors cite[1](https://pepvault.app/guides/glp-1s-and-menopause#source-1). The one direct report points the other way, and it is a single case: a 51-year-old on oral estradiol whose hot flashes and mood worsened while her semaglutide dose was being raised, and settled when the increases were slowed[7](https://pepvault.app/guides/glp-1s-and-menopause#source-7).

**Commonly reported:** the waist shrinking along with the scale, evening hunger going quiet, and a split on hot flashes, with some women saying they eased as weight came off and others noticing no change.

## Can a GLP-1 affect the pill or oral HRT?

Tirzepatide can, for a few weeks at a time. It slows how fast the stomach empties, most of all after the first dose, and that changes how pills are absorbed. With a single 5 mg dose, peak levels of a combined birth-control pill's hormones fell 55 to 66%, and total exposure fell 20 to 23%[4](https://pepvault.app/guides/glp-1s-and-menopause#source-4). So Zepbound's label tells women on an oral contraceptive to switch to a non-oral method, or add a barrier method, for 4 weeks after starting and for 4 weeks after each dose increase; hormonal methods that are not taken by mouth should not be affected[4](https://pepvault.app/guides/glp-1s-and-menopause#source-4). Perimenopause still counts here: until menopause is confirmed, pregnancy is possible, and the labels advise stopping semaglutide at least 2 months before a planned pregnancy and stopping tirzepatide once a pregnancy is known[4](https://pepvault.app/guides/glp-1s-and-menopause#source-4) [5](https://pepvault.app/guides/glp-1s-and-menopause#source-5).

Semaglutide's label lists ethinyl estradiol and levonorgestrel, two pill hormones, among the drugs whose levels showed no clinically significant change with it[5](https://pepvault.app/guides/glp-1s-and-menopause#source-5). For the progestogens taken by mouth in menopause hormone therapy, no interaction study with tirzepatide exists; a 2026 review calls an effect plausible but unproven, and most likely in the start and step-up weeks[6](https://pepvault.app/guides/glp-1s-and-menopause#source-6). The one report with semaglutide is the oral estradiol case above, and in the Mayo semaglutide study women on estradiol pills lost as much as those on patches[2](https://pepvault.app/guides/glp-1s-and-menopause#source-2) [7](https://pepvault.app/guides/glp-1s-and-menopause#source-7). Patches and gels skip the stomach altogether.

## What happens to muscle and bone?

Menopause already speeds the loss of muscle and bone, and a 2026 Mayo Clinic review names that as the main concern for midlife women on these drugs[10](https://pepvault.app/guides/glp-1s-and-menopause#source-10). Lean mass falls roughly in step with the weight lost, often with better physical function reported, but few trials have measured strength, and bone results so far are inconsistent[10](https://pepvault.app/guides/glp-1s-and-menopause#source-10). How much of the loss is muscle, and what protects it, is covered in our guide to muscle on a GLP-1.

Bone has one hard number, from Wegovy's label. In SELECT, the heart-outcomes trial in adults with established cardiovascular disease and overweight or obesity, more hip and pelvis fractures were reported on Wegovy than on placebo in women: 1% (24 of 2,448) against 0.2% (5 of 2,424). The gap was also seen in people 75 and older[5](https://pepvault.app/guides/glp-1s-and-menopause#source-5). A 2026 meta-analysis of placebo-controlled trials found a small drop in spine bone density, about 0.02 g/cm², and no change at the hip over 12 to 52 weeks; 11 of its 12 trials used older GLP-1s, the other semaglutide 1 mg, and none tested semaglutide 2.4 mg or tirzepatide[8](https://pepvault.app/guides/glp-1s-and-menopause#source-8).

The menopause society's statement pairs the drug with resistance training, enough protein and a check on fracture risk[9](https://pepvault.app/guides/glp-1s-and-menopause#source-9). Bone density is measured with a DXA scan, the low-dose X-ray the bone trials used[8](https://pepvault.app/guides/glp-1s-and-menopause#source-8).

<!--promo-->

PepVault sets a daily protein target from your weight and logs meals by photo, so the protein half of that advice is easy to keep count of. [Track your food in PepVault](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-glp-1s-and-menopause-inline&mt=8)

<!--/promo-->

**When to get help** A fall that leaves pain in the hip or groin, or makes it hard to stand or walk, is a reason to be seen the same day.

## What do the trials not tell us yet?

- **Menopause stage was assigned afterwards**, mostly by age, so some women in the perimenopause group may have been placed wrongly[1](https://pepvault.app/guides/glp-1s-and-menopause#source-1).
- **The tirzepatide analysis was funded by Lilly and mostly written by its staff**, and reports only the 15 mg or highest tolerated dose against placebo[1](https://pepvault.app/guides/glp-1s-and-menopause#source-1).
- **The hormone therapy finding comes from two chart reviews** in one clinic system, 16 and 40 women on hormone therapy, with no randomisation[2](https://pepvault.app/guides/glp-1s-and-menopause#source-2) [13](https://pepvault.app/guides/glp-1s-and-menopause#source-13).
- **No trial has finished on hot flashes, sleep or mood** with a GLP-1[11](https://pepvault.app/guides/glp-1s-and-menopause#source-11).
- **Fracture data for tirzepatide and for the newer doses are thin**, and the bone trials so far were short[8](https://pepvault.app/guides/glp-1s-and-menopause#source-8) [10](https://pepvault.app/guides/glp-1s-and-menopause#source-10).

What the evidence does show is clear enough to act on: the weight comes off after menopause much as it does before, the waist follows, and the questions worth asking a prescriber are about bone, muscle and any oral hormones taken alongside.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-next&mt=8)

<!--/promo-->

## Sources

1. Tchang BG, Mihai AC, Stefanski A, et al. Body weight reduction in women treated with tirzepatide by reproductive stage: a post hoc analysis from the SURMOUNT program. Obesity (Silver Spring). 2025;33(5):851-860. [PubMed 40074721](https://pubmed.ncbi.nlm.nih.gov/40074721/)
2. Hurtado MD, Tama E, Fansa S, et al. Weight loss response to semaglutide in postmenopausal women with and without hormone therapy use. Menopause. 2024;31(4):266-274. [PubMed 38446869](https://pubmed.ncbi.nlm.nih.gov/38446869/)
3. Nicolau J, Blanco-Anesto J, Bonet A, et al. Effectiveness of low doses of semaglutide on weight loss and body composition among women in their menopause. Metab Syndr Relat Disord. 2025;23(1):70-76. [PubMed 39761057](https://pubmed.ncbi.nlm.nih.gov/39761057/)
4. Eli Lilly and Company. ZEPBOUND (tirzepatide) injection, prescribing information (DailyMed, SPL version 40, revised 08/2026): sections 7, 8.3 and 12.3. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b)
5. Novo Nordisk. WEGOVY (semaglutide) injection and tablets, prescribing information (DailyMed, SPL version 19, revised 06/2026): sections 6.1 (fractures), 8.3, 12.3 and 14. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b)
6. Viana DPDC, Invitti AL, Jacobsen L, Schor E. Tirzepatide and oral progestogens: a hypothesis-generating review of a biologically plausible pharmacokinetic interaction in gynaecologic disease control and menopausal hormone therapy. Maturitas. 2026;214:109116. [PubMed 42721915](https://pubmed.ncbi.nlm.nih.gov/42721915/)
7. Parker AE. Worsening vasomotor symptoms in the setting of estradiol and semaglutide: a case report. Menopause. 2025;32(12):1168-1170. [PubMed 40729307](https://pubmed.ncbi.nlm.nih.gov/40729307/)
8. Safargar M, Ahmadi N, Prabahar K, et al. The effect of glucagon-like peptide-1 receptor agonists on bone metabolism: a systematic review and meta-analysis of randomized placebo-controlled trials of predominantly first-generation agents. Bone. 2026;215:118160. [PubMed 42971377](https://pubmed.ncbi.nlm.nih.gov/42971377/)
9. Sánchez-Prieto M, Romero-Domínguez M, Orozco R, et al. Incretin-based therapies in peri- and postmenopausal women with obesity: an expert position statement from the Spanish Menopause Society. Maturitas. 2026;213:109101. [PubMed 42664617](https://pubmed.ncbi.nlm.nih.gov/42664617/)
10. Castaneda R, Pavlov K, Shufelt CL, Faubion SS. Incretin-based therapies in menopause: current landscape. Maturitas. 2026;215:109159. [PubMed 42933336](https://pubmed.ncbi.nlm.nih.gov/42933336/)
11. Mayo Clinic. The effect of tirzepatide on menopausal vasomotor symptoms and biological aging in post-menopausal women with obesity: a pilot study (NCT07218445). ClinicalTrials.gov. [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07218445)
12. Bally L (sponsor-investigator). Effects of combined menopausal hormone therapy and GLP-1 receptor agonist therapy on glucose and energy homeostasis in early postmenopausal women with or at risk of diabetes (NCT06715514). ClinicalTrials.gov. [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06715514)
13. Castaneda R, Bechenati D, Tama E, et al. The role of menopause hormone therapy in modulating tirzepatide-associated weight loss in postmenopausal women with overweight or obesity: a retrospective cohort study. Lancet Obstet Gynaecol Womens Health. 2026;2(2):e118-e128. [doi.org](https://doi.org/10.1016/S3050-5038%2825%2900145-1)

<!--promo-->

Newsletter · Weekly

## The weekly peptide briefing.

New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.

<!--/promo-->

## Next guide · GLP-1

Guide · GLP-1

### [Stopping a GLP-1: what happens to your weight](https://pepvault.app/guides/stopping-a-glp-1)

What happened to weight when semaglutide and tirzepatide were stopped in STEP 1, STEP 4 and SURMOUNT-4: how much came back, how fast, and what the labels say.

Read the next guide

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## In the library

- [Semaglutide Studied range: 0.25–2.4 mg](https://pepvault.app/peptides/semaglutide)
- [Tirzepatide Studied range: 2.5–15 mg](https://pepvault.app/peptides/tirzepatide)

## Related guides

- Guide · GLP-1s

  ### [Muscle on a GLP-1: how much of the weight lost is lean mass?](https://pepvault.app/guides/muscle-on-a-glp-1)

  How much weight lost on a GLP-1 is lean mass: SURMOUNT-1, STEP 1, the apitegromab and bimagrumab add-on trials, and what guidance says on protein and training.

  Read the guide
- Guide · GLP-1s

  ### [Tirzepatide week by week](https://pepvault.app/guides/tirzepatide-week-by-week)

  What to expect on tirzepatide week by week: the label's dose steps, when appetite and nausea change, weight loss from week 20 to year 3, and the plateau.

  Read the guide
- Guide · GLP-1s

  ### [Semaglutide week by week](https://pepvault.app/guides/semaglutide-week-by-week)

  What to expect on semaglutide week by week: the Wegovy label's dose steps, what the STEP trials saw at each stage, appetite, side effects and the plateau.

  Read the guide
- Guide · GLP-1s

  ### [Stopping a GLP-1: what happens to your weight](https://pepvault.app/guides/stopping-a-glp-1)

  What happened to weight when semaglutide and tirzepatide were stopped in STEP 1, STEP 4 and SURMOUNT-4: how much came back, how fast, and what the labels say.

  Read the guide

## Guides

- [All guides](https://pepvault.app/guides)
- [How we research](https://pepvault.app/guides/how-we-research)

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this guide

### Semaglutide

- [Semaglutide: the full reference](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

### Tirzepatide

- [Tirzepatide: the full reference](https://pepvault.app/peptides/tirzepatide)
- [Tirzepatide dose guide](https://pepvault.app/lab/dosage/tirzepatide)

### Mixing charts

- [Semaglutide 2 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-2mg)
- [Semaglutide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-5mg)
- [Semaglutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-10mg)
- [Tirzepatide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-5mg)
- [Tirzepatide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-10mg)
- [Tirzepatide 15 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-15mg)
- [Tirzepatide 30 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-30mg)
- [Tirzepatide 60 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-60mg)

### Studies

- [Semaglutide: 11.85% more weight loss than placebo without diabetes](https://pepvault.app/research/semaglutide-tan-2022)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [CagriSema: HbA1c down 2.33% at 40 weeks in REIMAGINE 3](https://pepvault.app/research/cagrisema-reimagine-3-2026)
- [All 31 studies](https://pepvault.app/research#semaglutide)
- [Tirzepatide plus apitegromab: 1.9 kg less lean mass loss in EMBRAZE](https://pepvault.app/research/tirzepatide-embraze-2026)
- [Tirzepatide SURMOUNT-MAINTAIN: 21.9% weight loss at 112 weeks](https://pepvault.app/research/tirzepatide-surmount-maintain-2026)
- [Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c](https://pepvault.app/research/dulaglutide-surpass-switch-2025)
- [All 19 studies](https://pepvault.app/research#tirzepatide)

### Compared with

- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)
- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)
- [Semaglutide vs Dulaglutide](https://pepvault.app/peptides/compare/semaglutide-vs-dulaglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### The GLP-1 path

- [Retatrutide week by week](https://pepvault.app/guides/retatrutide-week-by-week)
- [Retatrutide dosage: the trial step-ups](https://pepvault.app/guides/retatrutide-dosage-in-trials)
- [Tirzepatide week by week](https://pepvault.app/guides/tirzepatide-week-by-week)
- [Semaglutide week by week](https://pepvault.app/guides/semaglutide-week-by-week)
- [Tirzepatide dosage: every step from 2.5 to 15 mg (Mounjaro and Zepbound)](https://pepvault.app/guides/tirzepatide-dosage)
- [Wegovy and Ozempic dosage: both labels' steps in one table, and why the two differ](https://pepvault.app/guides/wegovy-and-ozempic-dosage)
- [How to use the Zepbound KwikPen](https://pepvault.app/guides/how-to-use-the-zepbound-kwikpen)
- [How to use the Ozempic and Wegovy pens: needles, the dose counter and clicks](https://pepvault.app/guides/how-to-use-ozempic-and-wegovy-pens)
- [What time of day to take your GLP-1 shot or pill, and can you change the day?](https://pepvault.app/guides/when-to-take-your-glp-1)
- [Switching GLP-1s: Ozempic to Zepbound, shot to pill, and what the trials tested](https://pepvault.app/guides/switching-between-glp-1s)
- [Ozempic vs Wegovy vs Mounjaro vs Zepbound: the four labels in one table](https://pepvault.app/guides/ozempic-wegovy-mounjaro-zepbound)
- [Is Ozempic insulin? GLP-1, GIP and insulin explained](https://pepvault.app/guides/is-ozempic-insulin)
- [The Wegovy pill: what it is, how its label differs from the shot, and the trial numbers](https://pepvault.app/guides/the-wegovy-pill)
- [Ozempic and Wegovy side effects: what the trials counted and when they showed up](https://pepvault.app/guides/ozempic-and-wegovy-side-effects)
- [Semaglutide vs tirzepatide side effects: what the head-to-head trials found](https://pepvault.app/guides/sema-vs-tirzepatide-side-effects)
- [Microdosing a GLP-1: what it means and what has been tested](https://pepvault.app/guides/microdosing-a-glp-1)
- [GLP-1s and sleep apnea: Zepbound's OSA approval](https://pepvault.app/guides/glp-1-and-sleep-apnea)
- [Retatrutide first dose: the first four weeks in the trials](https://pepvault.app/guides/retatrutide-first-dose)
- [Retatrutide side effects: what the trials counted](https://pepvault.app/guides/retatrutide-side-effects)
- [Retatrutide not working? Stalls, slow responders and the plateau](https://pepvault.app/guides/retatrutide-not-working)
- [Switching from tirzepatide to retatrutide: what is known](https://pepvault.app/guides/tirzepatide-to-retatrutide)
- [Is retatrutide safe? What the trials reported](https://pepvault.app/guides/is-retatrutide-safe)
- [When will retatrutide be approved?](https://pepvault.app/guides/when-will-retatrutide-be-approved)
- [TRIUMPH-5 results: retatrutide vs tirzepatide head to head](https://pepvault.app/guides/triumph-5-results)
- [CagriSema FDA approval: when it's due, the dose filed, and what the trials showed](https://pepvault.app/guides/cagrisema-fda-decision)
- [MariTide phase 3 results (MARITIME-1): what to expect](https://pepvault.app/guides/maritime-1-results)
- [Aleniglipron: the GLP-1 pill, and the trial switching people from shots to it](https://pepvault.app/guides/aleniglipron-switch-trial)
- [Mounjaro and Zepbound side effects by dose: the rates at each step](https://pepvault.app/guides/mounjaro-zepbound-side-effects)
- [Hair loss on a GLP-1: how common it is per drug, and why](https://pepvault.app/guides/hair-loss-on-a-glp-1)
- ["Ozempic face": what it is, and where the weight comes from](https://pepvault.app/guides/ozempic-face)
- [Foundayo (orforglipron) vs the shots: the trial numbers side by side](https://pepvault.app/guides/foundayo-vs-the-shots)
- [Is compounded semaglutide or tirzepatide the same as Ozempic or Zepbound?](https://pepvault.app/guides/compounded-glp-1-vs-brand)
- [Why compounded semaglutide and tirzepatide come with B12, glycine or B6, and what it changes](https://pepvault.app/guides/compounded-glp-1-with-b12)
- [Is there a generic Ozempic? Generic semaglutide and Sevmia](https://pepvault.app/guides/generic-semaglutide)
- [How much does a GLP-1 cost in 2026? Zepbound, Wegovy and Medicare prices](https://pepvault.app/guides/how-much-does-a-glp-1-cost)
- [What to eat on a GLP-1: what the trials and the guidelines say](https://pepvault.app/guides/what-to-eat-on-a-glp-1)
- [How much protein per day? The numbers by weight and goal](https://pepvault.app/guides/how-much-protein-per-day)
- [Muscle on a GLP-1: how much of the weight lost is lean mass?](https://pepvault.app/guides/muscle-on-a-glp-1)
- [Intermittent fasting on a GLP-1: what the trials and labels say](https://pepvault.app/guides/intermittent-fasting-on-a-glp-1)
- [Coffee on a GLP-1: can you drink it, and why it can taste different](https://pepvault.app/guides/coffee-on-a-glp-1)
- [Food noise on a GLP-1: what it is and what happens after stopping](https://pepvault.app/guides/food-noise-on-a-glp-1)
- [Stopping a GLP-1: what happens to your weight](https://pepvault.app/guides/stopping-a-glp-1)
- [How to keep the weight off after a GLP-1: what each trial tested](https://pepvault.app/guides/keeping-weight-off-after-a-glp-1)
- [Berberine vs metformin vs a GLP-1: what each does to weight and glucose](https://pepvault.app/guides/berberine-vs-metformin-vs-glp-1)
- [Natural GLP-1 alternatives: what the evidence shows for berberine, fiber and supplements](https://pepvault.app/guides/natural-glp-1-alternatives)
- [What is 5-Amino-1MQ? What's been measured](https://pepvault.app/guides/5-amino-1mq-explained)
- [Retatrutide from a lab vial: what independent testing found](https://pepvault.app/guides/retatrutide-lab-vial-tests)
- [Switching from Saxenda to Wegovy: how the change works](https://pepvault.app/guides/saxenda-to-wegovy)
- [Do you stop Ozempic, Wegovy, Mounjaro or Zepbound before surgery?](https://pepvault.app/guides/glp-1-before-surgery)
- [Diarrhea on a GLP-1: how common, and how long it lasts](https://pepvault.app/guides/diarrhea-on-a-glp-1)
- [Dizziness on a GLP-1: dehydration, blood pressure or blood sugar?](https://pepvault.app/guides/dizziness-on-a-glp-1)
- [Heartburn and acid reflux on a GLP-1: the rates, the timing and what helps](https://pepvault.app/guides/heartburn-on-a-glp-1)
- [Does Ozempic or Mounjaro make you tired? Fatigue in the trials](https://pepvault.app/guides/glp-1-fatigue)
- [Can a GLP-1 cause low blood sugar if you do not have diabetes?](https://pepvault.app/guides/glp-1-low-blood-sugar)
- [Is there a medicine for GLP-1 nausea? Tradipitant, so far](https://pepvault.app/guides/tradipitant-for-glp-1-nausea)
- [GLP-1s and mood: depression, anxiety and what the FDA review found](https://pepvault.app/guides/glp-1s-and-mood)
- [Can Ozempic cause vision loss? GLP-1s and NAION, by the numbers](https://pepvault.app/guides/glp-1-and-naion)
- [Are GLP-1s safe long term? What the longest trials show](https://pepvault.app/guides/are-glp-1s-safe-long-term)
- [GLP-1s and the kidneys: what FLOW showed, and the dehydration risk](https://pepvault.app/guides/glp-1s-and-the-kidneys)
- [Can you drink alcohol on Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/alcohol-on-a-glp-1)
- [Do GLP-1s reduce alcohol cravings? What the trials found](https://pepvault.app/guides/glp-1-and-alcohol-cravings)
- [GLP-1s and fatty liver: what the trials measured](https://pepvault.app/guides/glp-1-and-fatty-liver)
- [GLP-1s after a gastric sleeve or bypass: regain, dosing and sleeve vs GLP-1](https://pepvault.app/guides/glp-1-after-bariatric-surgery)
- [Can you drink alcohol on retatrutide?](https://pepvault.app/guides/retatrutide-and-alcohol)
- [Ozempic, Wegovy, Mounjaro or Zepbound not working? Slow responders and plateaus in the trials](https://pepvault.app/guides/glp-1-not-working)
- [Intermittent fasting for weight and fat loss: what the trials measured](https://pepvault.app/guides/intermittent-fasting-weight-loss)
- [Can you take metformin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/metformin-with-a-glp-1)
- [GLP-1s and pregnancy: Ozempic, Wegovy, Mounjaro and Zepbound before and during](https://pepvault.app/guides/glp-1s-and-pregnancy)
- [Can you take Ozempic, Mounjaro or another GLP-1 while breastfeeding?](https://pepvault.app/guides/glp-1-while-breastfeeding)
- [Eloralintide, petrelintide and amycretin: the amylin drugs in trials](https://pepvault.app/guides/amylin-drugs-in-trials)
- [Olatorepatide (HS-20094): Regeneron's obesity drug, what is known so far](https://pepvault.app/guides/olatorepatide-explained)
- [Cagrilintide and CagriSema: what amylin adds to semaglutide](https://pepvault.app/guides/cagrilintide-and-cagrisema)
- [Berobenatide (PF-08653944, MET-097i): Pfizer's monthly GLP-1 shot, what is known so far](https://pepvault.app/guides/berobenatide-explained)
- [The GLP-1 pipeline: every drug in phase 2 and 3, and when its trials finish](https://pepvault.app/guides/glp-1-pipeline)
- [Is there a monthly GLP-1 shot? MariTide and berobenatide](https://pepvault.app/guides/monthly-glp-1-shots)
- [Cagrilintide alone: RENEW 1 phase 3 results and what to expect](https://pepvault.app/guides/renew-1-cagrilintide-results)
- [Wegovy HD: is 7.2 mg worth it, and what changes from 2.4 mg](https://pepvault.app/guides/wegovy-hd-7-2-mg)
- [Zenagamtide (amycretin): Novo's GLP-1 and amylin shot and pill, what the trials show](https://pepvault.app/guides/zenagamtide-amycretin)
- [Wegovy and Ozempic price, Medicare and WADA: what changes on January 1, 2027](https://pepvault.app/guides/glp-1-changes-january-2027)
- [Can you take sermorelin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/sermorelin-with-a-glp-1)
- [Retatrutide in women: what the studies included](https://pepvault.app/guides/retatrutide-in-women)
- [Peptides for women: what the trials in women show, and after 40](https://pepvault.app/guides/peptides-for-women)
- [Low-dose naltrexone (LDN) for weight loss: what the trials measured](https://pepvault.app/guides/ldn-for-weight-loss)
- [GLP-1s and PCOS: what the trials show, and how they compare with metformin](https://pepvault.app/guides/glp-1-and-pcos)
- [GLP-1s and sleep: insomnia, vivid dreams and the sleep apnea approval](https://pepvault.app/guides/glp-1s-and-sleep)

### Terms on this page

- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Meta-analysis](https://pepvault.app/glossary/meta-analysis)
- [Post hoc analysis](https://pepvault.app/glossary/post-hoc-analysis)
- [HbA1c (A1C)](https://pepvault.app/glossary/hba1c)
- [Body mass index (BMI)](https://pepvault.app/glossary/bmi)
- [Lean mass](https://pepvault.app/glossary/lean-mass)

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
